Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
13.15
0.25 (1.94%)
At close: Aug 15, 2025, 3:59 PM
13.20
0.38%
After-hours: Aug 15, 2025, 05:41 PM EDT

Ginkgo Bioworks Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-60.3M -90.96M -107.53M -56.4M -217.18M -165.91M -211.69M -302.89M -173.31M -204.97M -174.15M -669.05M -670.57M -592.59M -1.6B -102.41M -54.46M -74.78M
Depreciation & Amortization
15.79M 15.37M 15.65M 17.17M 17.33M 12.87M 12.84M 20.49M 18.22M 18.96M 15.82M 9.51M 9.61M 9.49M 8M 8.28M 7.17M 5.63M
Stock-Based Compensation
22.25M 20.43M 20.56M 13.86M 37.15M 40.78M 42.84M 52.57M 61.49M 72.99M 108.17M 563.14M 606.51M 652.82M 1.59B 127K 14.52M 118K
Other Working Capital
-15.45M -13.29M -35.07M 40.77M 219K -3.79M 9.52M 219K -21.81M -9.52M -41.18M -9.74M -34.3M 3.86M -7.55M 43.64M 6.56M 12.78M
Other Non-Cash Items
4.72M 15.2M 26.71M -71.93M 72.44M 22.69M 47.66M 11.27M 31.89M 20.95M -21.18M 23.25M 8.12M -79.47M -9.58M -6.98M -6.21M 1.82M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -801K 146.84M 67K n/a -14.61M n/a n/a n/a -57.88M 70.5M 1.59M 16M
Change in Working Capital
-22.71M -11.56M 2.18M -6.19M 5.88M 312K 51.33M -1.82M -11.88M 1.49M -18.75M 44.86M -52.97M -10.15M -92.34M 25.25M 2.49M 3.07M
Operating Cash Flow
-40.25M -51.52M -42.44M -103.5M -84.39M -89.26M -57.83M -73.55M -73.53M -90.58M -104.7M -28.3M -99.3M -19.9M -165.54M -5.24M -34.91M -48.13M
Capital Expenditures
-38K -7.62M -13.71M -15.09M -27.03M -6.71M -3.45M -4.38M -13.53M -19.44M -25.64M -13.47M -9.57M -3.58M -5.11M -5.44M -24.03M -21.93M
Cash Acquisitions
n/a n/a 57K -191K n/a -5.4M -41.55M 74K 2.31M 617K 83.02M -29.05M 1.44M -28.77M 9.34M -20.17M n/a -1.21M
Purchase of Investments
-128.95M -191.18M n/a n/a n/a n/a n/a n/a n/a n/a 10M -10M -6.5M -3.69M -5M -5M n/a -1.73B
Sales Maturities Of Investments
64.96M n/a 568K 3.95M n/a n/a n/a n/a n/a n/a n/a n/a 6.5M n/a 4.7M -124.3K 124.3K n/a
Other Investing Acitivies
142K 120K n/a 1.13M 191K n/a -1.68M 926K 2.31M -590K -37.64M 6.03M -6.53M 58K 304K 102K 103K 99K
Investing Cash Flow
-63.89M -198.68M -13.09M -10.2M -26.84M -12.11M -46.67M -3.38M -11.22M -19.41M 29.74M -46.49M -14.66M -35.98M 4.23M -30.51M -23.93M -23.05M
Debt Repayment
-98K -207K -203K -200K -200K -294K -318K -329K -326K -322K -155K -303K -434K -286K -359K -316K -163K -285K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a -12K n/a n/a n/a -75K -981K -9.46M -25M n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a -554K n/a n/a n/a n/a n/a n/a n/a -24.96M n/a n/a n/a
Other Financial Acitivies
n/a n/a 4K -265K -40K -621K 727K 14K -1.05M -566K -1.22M -88K -334K -906K -1.22M 1.55B -1.96M -148K
Financial Cash Flow
-98K -207K -203K -465K -226K -845K -632K -315K -1.38M -888K 97.93M -450K -954K -1.19M -11.04M 1.55B -2.12M -433K
Net Cash Flow
-105.85M -250.34M -55.8M -114.2M -111.47M -102.37M -105.03M -77.44M -86.61M -110.91M 24.07M -75.33M -115.01M -57.08M -172.37M 1.51B -60.97M -71.61M
Free Cash Flow
-40.29M -59.14M -56.15M -118.59M -111.42M -95.97M -52M -77.93M -87.07M -110.03M -130.35M -41.77M -108.87M -23.48M -170.66M -10.67M -58.95M -70.07M